Requirement of VPS33B, a member of the Sec1/Munc18 protein family, in megakaryocyte and platelet α-granule biogenesis

Blood

Volumn 106, Issue 13, 2005, Pages 4159-4166

  Lo, Bryan ^b   Li, Ling ^b   Gissen, Paul ^b   Christensen, Hilary ^b   McKiernan, Patrick J ^b   Ye, Charles ^b   Abdelhaleem, Mohamed ^b   Hayes, Jason A ^b   Williams, Michael D ^b   Chitayat, David ^b   Kahr, Walter H A ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; PROTEIN SUBUNIT;

ARTHROGRYPOSIS; ARTICLE; BIOGENESIS; CELL VACUOLE; COMPLEX FORMATION; CONTROLLED STUDY; ENDOSOME; FIBROBLAST; FILM; GOLGI COMPLEX; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; LYSOSOME; MEGAKARYOCYTE; MEMBRANE BINDING; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; THROMBOCYTE;

EID: 28844469933     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-04-1356     Document Type: Article

References (77)

1. Huizing M, Boissy RE, Gahl WA. Hermansky-Pudlak syndrome: vesicle formation from yeast to man. Pigment Cell Res. 2002;15:405-419.
2. Gunay-Aygun M, Huizing M, Gahl WA. Molecular defects that affect platelet dense granules. Semin Thromb Hemost. 2004;30:537-547.
3. Li W, Rusiniak ME, Chintala S, Gautam R, Novak EK, Swank RT. Murine Hermansky-Pudlak syndrome genes: regulators of lysosome-related organelles. Bioessays. 2004;26:616-628.
4. McNicol A, Israels SJ. Platelet dense granules: structure, function and implications for haemostasis. Thromb Res. 1999;95:1-18.
5. Huizing M, Anikster Y, Gahl WA. Hermansky-Pudlak syndrome and Chediak-Higashi syndrome: disorders of vesicle formation and trafficking. Thromb Haemost. 2001;86:233-245.
6. Introne W, Boissy RE, Gahl WA. Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome. Mol Genet Metab. 1999;68:283-303.
7. Dell'Angelica EC. The building BLOC(k)s of lysosomes and related organelles. Curr Opin Cell Biol. 2004;16:458-464.
8. Freson K, Devriendt K, Matthijs G, et al. Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation. Blood. 2001;98:85-92.
9. Favier R, Jondeau K, Boutard P, et al. Paris-Trousseau syndrome: clinical, hematological, molecular data of ten new cases. Thromb Haemost. 2003;90:893-897.
10. Raslova H, Komura E, Le Couedic JP, et al. FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau/Jacobsen thrombopenia. J Clin Invest. 2004;114:77-84.
11. Shivdasani RA, Rosenblatt MF, Zucker-Franklin D, et al. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell. 1995;81:695-704.
12. Kimura Y, Hart A, Hirashima M, et al. Zinc finger protein, Hzf, is required for megakaryocyte development and hemostasis. J Exp Med. 2002;195:941-952.
13. Kato K, Martinez C, Russell S, et al. Genetic deletion of mouse platelet glycoprotein Ibbeta produces a Bernard-Soulier phenotype with increased alpha-granule size. Blood. 2004;104:2339-2344.
14. Watanabe R, Ishibashi T, Saitoh Y, et al. Bernardsoulier syndrome with a homozygous 13 base pair deletion in the signal peptide-coding region of the platelet glycoprotein Ib(beta) gene. Blood Coagul Fibrinolysis. 2003;14:387-394.
15. Novak EK, Reddington M, Zhen L, et al. Inherited thrombocytopenia caused by reduced platelet production in mice with the gunmetal pigment gene mutation. Blood. 1995;85:1781-1789.
16. Swank RT, Jiang SY, Reddington M, et al. Inherited abnormalities in platelet organelles and platelet formation and associated altered expression of low molecular weight guanosine triphosphatebinding proteins in the mouse pigment mutant gunmetal. Blood. 1993;81:2626-2635.
17. Tiwari S, Italiano JE Jr, Barral DC, et al. A role for Rab27b in NF-E2-dependent pathways of platelet formation. Blood. 2003;102:3970-3979.
18. Kahr WH, Zheng S, Sheth PM, et al. Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator. Blood. 2001;98:257-265.
19. Raccuglia G. Gray platelet syndrome: a variety of qualitative platelet disorder. Am J Med. 1971;51:818-828.
20. White JG. Ultrastructural studies of the gray platelet syndrome. Am J Pathol. 1979;95:445-462.
21. Cramer EM, Vainchenker W, Vinci G, Guichard J, Breton-Gorius J. Gray platelet syndrome: immunoelectron microscopic localization of fibrinogen and von Willebrand factor in platelets and megakaryocytes. Blood. 1985;66:1309-1316.
22. Smith MP, Cramer EM, Savidge GF. Megakaryocytes and platelets in alpha-granule disorders. Baillieres Clin Haematol. 1997;10:125-148.
23. Falik-Zaccai TC, Anikster Y, Rivera CE, et al. A new genetic isolate of gray platelet syndrome (GPS): clinical, cellular, and hematologic characteristics. Mol Genet Metab. 2001;74:303-313.
24. Lutz-Richner AR, Landolt RF. Familiäre Gallengangsmissbildungen mit tubulärer Niereninsuffizienz. Helv Paediatr Acta. 1973;28:1-12.
25. Abdullah MA, Al-Hasnan Z, Okamoto E, Abomelha AM. Arthrogryposis, renal dysfunction and cholestasis syndrome. Saudi Med J. 2000;21:297-299.
26. Eastham KM, McKiernan PJ, Milford DV, et al. ARC syndrome: an expanding range of phenotypes. Arch Dis Child. 2001;85:415-420.
27. Hayes JA, Kahr WH, Lo B, Macpherson BA. Liver biopsy complicated by hemorrhage in a patient with ARC syndrome. Paediatr Anaesth. 2004;14:960-963.
28. Gissen P, Johnson CA, Morgan NV, et al. Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposisrenal dysfunction-cholestasis (ARC) syndrome. Nat Genet. 2004;36:400-404.
29. Di Rocco M, Callea F, Pollice B, Faraci M, Campiani F, Borrone C. Arthrogryposis, renal dysfunction and cholestasis syndrome: report of five patients from three Italian families. Eur J Pediatr. 1995;154:835-839.
30. Coleman RA, Van Hove JL, Morris CR, Rhoads JM, Summar ML. Cerebral defects and nephrogenic diabetes insipidus with the ARC syndrome: additional findings or a new syndrome (ARCCNDI)? Am J Med Genet. 1997;72:335-338.
31. Deal JE, Barratt TM, Dillon MJ. Fanconi syndrome, ichthyosis, dysmorphism, jaundice and diarrhoea - a new syndrome. Pediatr Nephrol. 1990;4:308-313.
32. Goodall AH, Appleby J. Flow-cytometric analysis of platelet-membrane glycoprotein expression and platelet activation. Methods Mol Biol. 2004;272:225-253.
33. Jarvis GE. Platelet aggregation: turbidimetric measurements. Methods Mol Biol. 2004;272:65-76.
34. Pujol-Moix N, Hernandez A, Escolar G, Espanol I, Martinez-Brotons F, Mateo J. Platelet ultrastructural morphometry for diagnosis of partial deltastorage pool disease in patients with mild platelet dysfunction and/or thrombocytopenia of unknown origin: a study of 24 cases. Haematologica. 2000;85:619-626.
35. Weiss HJ, Witte LD, Kaplan KL, et al. Heterogeneity in storage pool deficiency: studies on granule-bound substances in 18 patients including variants deficient in alpha-granules, platelet factor 4, beta-thromboglobulin, and platelet-derived growth factor. Blood. 1979;54:1296-1319.
36. Gerrard JM, Phillips DR, Rao GH, et al. Biochemical studies of two patients with the gray platelet syndrome: selective deficiency of platelet alpha granules. J Clin Invest. 1980;66:102-109.
37. Harrison P, Cramer EM. Platelet alpha-granules. Blood Rev. 1993;7:52-62.
38. Rosa JP, George JN, Bainton DF, Nurden AT, Caen JP, McEver RP. Gray platelet syndrome: demonstration of alpha granule membranes that can fuse with the cell surface. J Clin Invest. 1987;80:1138-1146.
39. Huizing M, Didier A, Walenta J, Anikster Y, Gahl WA, Kramer H. Molecular cloning and characterization of human VPS18, VPS11, VPS16, and VPS33. Gene. 2001;264:241-247.
40. Heijnen HF, Debili N, Vainchencker W, Breton-Gorius J, Geuze HJ, Sixma JJ. Multivesicular bodies are an intermediate stage in the formation of platelet alpha-granules. Blood. 1998;91:2313-2325.
41. Hunziker W, Geuze HJ. Intracellular trafficking of lysosomal membrane proteins. Bioessays. 1996;18:379-389.
42. Lages B, Sussman, II, Levine SP, Coletti D,Weiss HJ. Platelet alpha granule deficiency associated with decreased P-selectin and selective impairment of thrombin-induced activation in a new patient with gray platelet syndrome (alpha-storage pool deficiency). J Lab Clin Med. 1997;129:364-375.
43. Youssefian T, Cramer EM. Megakaryocyte dense granule components are sorted in multivesicular bodies. Blood. 2000;95:4004-4007.
44. Barr FA, Short B. Golgins in the structure and dynamics of the Golgi apparatus. Curr Opin Cell Biol. 2003;15:405-413.
45. King SM, Reed GL. Development of platelet secretory granules. Semin Cell Dev Biol. 2002;13:293-302.
46. Cramer EM, Caen JP, Drouet L, Breton-Gorius J. Absence of tubular structures and immunolabeling for von Willebrand factor in the platelet alphagranules from porcine von Willebrand disease. Blood. 1986;68:774-778.
47. Cramer EM, Meyer D, le Menn R, Breton-Gorius J. Eccentric localization of von Willebrand factor in an internal structure of platelet alpha-granule resembling that of Weibel-Palade bodies. Blood. 1985;66:710-713.
48. Sander HJ, Slot JW, Bouma BN, Bolhuis PA, Pepper DS, Sixma JJ. Immunocytochemical localization of fibrinogen, platelet factor 4, and beta thromboglobulin in thin frozen sections of human blood platelets. J Clin Invest. 1983;72:1277-1287.
49. Coppinger JA, Cagney G, Toomey S, et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood. 2004;103:2096-2104.
50. Schmitt A, Guichard J, Masse JM, Debili N, Cramer EM. Of mice and men: comparison of the ultrastructure of megakaryocytes and platelets. Exp Hematol. 2001;29:1295-1302.
51. Hartwig J, Italiano J Jr. The birth of the platelet. J Thromb Haemost. 2003;1:1580-1586.
52. Sporn LA, Chavin SI, Marder VJ, Wagner DD. Biosynthesis of von Willebrand protein by human megakaryocytes. J Clin Invest. 1985;76:1102-1106.
53. Michaux G, Cutler DF. How to roll an endothelial cigar: the biogenesis of Weibel-Palade bodies. Traffic. 2004;5:69-78.
54. Gebrane-Younes J, Cramer EM, Orcel L, Caen JP. Gray platelet syndrome: dissociation between abnormal sorting in megakaryocyte alpha-granules and normal sorting in Weibel-Palade bodies of endothelial cells. J Clin Invest. 1993;92:3023-3028.
55. Drouin A, Favier R, Masse JM, et al. Newly recognized cellular abnormalities in the gray platelet syndrome. Blood. 2001;98:1382-1391.
56. Handagama P, Bainton DF, Jacques Y, Conn MT, Lazarus RA, Shuman MA. Kistrin, an integrin antagonist, blocks endocytosis of fibrinogen into guinea pig megakaryocyte and platelet alphagranules. J Clin Invest. 1993;91:193-200.
57. Handagama P, Scarborough RM, Shuman MA, Bainton DF. Endocytosis of fibrinogen into megakaryocyte and platelet alpha-granules is mediated by alpha IIb beta 3 (glycoprotein IIb-IIIa). Blood. 1993;82:135-138.
58. Harrison P, Wilbourn B, Debili N, et al. Uptake of plasma fibrinogen into the alpha granules of human megakaryocytes and platelets. J Clin Invest. 1989;84:1320-1324.
59. Nurden AT, Kunicki TJ, Dupuis D, Soria C, Caen JP. Specific protein and glycoprotein deficiencies in platelets isolated from two patients with the gray platelet syndrome. Blood. 1982;59:709-718.
60. Furie B, Furie BC, Flaumenhaft R. A journey with platelet P-selectin: the molecular basis of granule secretion, signalling and cell adhesion. Thromb Haemost. 2001;86:214-221.
61. Israels SJ, Gerrard JM, Jacques YV, et al. Platelet dense granule membranes contain both granulophysin and P-selectin (GMP-140). Blood. 1992;80:143-152.
62. Youssefian T, Masse JM, Rendu F, Guichard J, Cramer EM. Platelet and megakaryocyte dense granules contain glycoproteins Ib and IIb-IIIa. Blood. 1997;89:4047-4057.
63. Mazurov AV, Vinogradov DV, Khaspekova SG, Krushinsky AV, Gerdeva LV, Vasiliev SA. Deficiency of P-selectin in a patient with grey platelet syndrome. Eur J Haematol. 1996;57:38-41.
64. Toonen RF, Verhage M. Vesicle trafficking: pleasure and pain from SM genes. Trends Cell Biol. 2003;13:177-186.
65. Jahn R, Lang T, Südhof TC. Membrane fusion. Cell. 2003;112:519-533.
66. Rizo J, Südhof TC. Snares and Munc18 in synaptic vesicle fusion. Nat Rev Neurosci. 2002;3:641-653.
67. Gallwitz D, Jahn R. The riddle of the Sec1/Munc-18 proteins: new twists added to their interactions with SNAREs. Trends Biochem Sci. 2003;28:113-116.
68. Houng A, Polgar J, Reed GL. Munc18-syntaxin complexes and exocytosis in human platelets. J Biol Chem. 2003;278:19627-19633.
69. Schraw TD, Lemons PP, Dean WL, Whiteheart SW. A role for Sec1/Munc18 proteins in platelet exocytosis. Biochem J. 2003;374:207-217.
70. Schraw TD, Crawford GL, Ren Q, et al. Platelets from Munc18c heterozygous mice exhibit normal stimulus-induced release. Thromb Haemost. 2004;92:829-837.
71. Gissen P, Johnson CA, Gentle D, et al. Comparative evolutionary analysis of VPS33 homologues: genetic and functional insights. Hum Mol Genet. 2005;14:1261-1270.
72. Suzuki T, Oiso N, Gautam R, et al. The mouse organellar biogenesis mutant buff results from a mutation in Vps33a, a homologue of yeast vps33 and Drosophila carnation. Proc Natl Acad Sci U S A. 2003;100:1146-1150.
73. Sato TK, Rehling P, Peterson MR, Emr SD. Class C Vps protein complex regulates vacuolar SNARE pairing and is required for vesicle docking/fusion. Mol Cell. 2000;6:661-671.
74. Wurmser AE, Sato TK, Emr SD. New component of the vacuolar class C-Vps complex couples nucleotide exchange on the Ypt7 GTPase to SNAREdependent docking and fusion. J Cell Biol. 2000;151:551-562.
75. Peterson MR, Emr SD. The class C Vps complex functions at multiple stages of the vacuolar transport pathway. Traffic. 2001;2:476-486.
76. Subramanian S, Woolford CA, Jones EW. The Sec1/Munc18 protein, Vps33p, functions at the endosome and the vacuole of Saccharomyces cerevisiae. Mol Biol Cell. 2004;15:2593-2605.
77. Collins KM, Thorngren NL, Fratti RA, Wickner WT. Sec17p and HOPS, in distinct SNARE complexes, mediate SNARE complex disruption or assembly for fusion. Embo J. 2005;24:1775-1786.